A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age
Clinical trial NCT05701800 · TERMINATED
Trial details
- NCT number
- NCT05701800
- Sponsor
- ModernaTX, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2025-12-31
- Enrollment
- 659
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.